Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of mapatumumab plus paclitaxel and carboplatin in advanced NSCLC
2007-005153-32Phase 2Completed
- Sponsor
- Human Genome Sciences
- Start
- Dec 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mapatumumab in non-small cell lung cancer (NSCLC), sponsored by Human Genome Sciences. Started Dec 2007; status: completed.
02
Drugs
mapatumumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-005153-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005153-32.